College of Economics and Management, Jiangxi Agricultural University, Nanchang, Jiangxi, China.
Department of Agricultural and Resource Economics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
GM Crops Food. 2022 Dec 31;13(1):86-96. doi: 10.1080/21645698.2022.2068336.
China has been investing heavily in biotechnology to increase agricultural productivity. While a number of Chinese developed GM crops have cleared the required scientific hurdles - some more than a decade ago - commercialization has not been approved. The regulatory regime for GMOs in China is relatively less well understood than that of the US or the EU. This paper provides a systematic overview of China's regulatory regime, R&D investment and delayed commercialization decisions on biotechnology over the last 40 years and draws some conclusions regarding the likelihood of the commercialization for major GM crops in the future.
中国一直在大力投资生物技术，以提高农业生产力。尽管一些中国开发的转基因作物已经通过了必要的科学障碍——有些甚至是在十多年前——但它们仍未获得商业化批准。与美国或欧盟相比，中国对转基因生物的监管机制相对不太为人所知。本文对中国过去 40 年来在生物技术方面的监管机制、研发投资和延迟商业化决策进行了系统的概述，并就未来主要转基因作物商业化的可能性得出了一些结论。
